The European Medicines Agency is set to rule on the safety of the single-dose Johnson & Johnson vaccine today.
A press conference is expected to be held in Amsterdam later today in relation to its ruling. This follows blood-clot concerns that are believed to be linked to the vaccine which has led to its doses being paused in the US while an investigation was launched to determine if there was a link.
Four blood clots were reported with one being fatal after the Johnson & Johnson vaccine was administered. The four cases were reviewed today and the findings will be revealed at the press conference.
Despite the blood clots, the EMA has stated that it’s a small number out of the millions of vaccines that have been administered with health officials adding that it’s also an extremely rare side effect.